Neurostar RTMS denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for neurostar rtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Requires Prior Authorization for NeuroStar TMS — and How to Obtain It (or Appeal a Denial)

NeuroStar TMS (transcranial magnetic stimulation) is a covered benefit under many UnitedHealthcare plans, but it is universally subject to prior authorization — meaning UHC must approve the treatment before it is administered in order for coverage to apply. A prior-authorization denial is distinct from a finding that TMS is clinically inappropriate; it often means the submitted request lacked required documentation, was submitted by the wrong entity, or did not address all of UHC's coverage criteria in the initial submission.

### Why This Denial Is Appealable

If prior authorization was denied on clinical grounds — rather than simply being an administrative incomplete submission — you have full appeal rights under ACA Section 2719 (for non-grandfathered commercial plans) and ERISA Section 503 (for employer-sponsored plans). UHC must provide a specific clinical reason for any adverse prior-authorization determination and must allow you to submit additional information. Independent external review is available after an adverse internal appeal decision.

### Your Appeal Timeline

• Internal appeal: File within the window on your denial letter (commonly 180 days). Pre-service appeals must be decided within 30 days.
• Reconsideration vs. appeal: Check whether UHC offers a "peer-to-peer" review option — a direct call between your psychiatrist and UHC's medical director — before the formal appeal. This is often faster and can resolve documentation gaps without a full appeal.
• External review: If internal appeal is adverse, you generally have four months to request independent external review. The reviewer's decision is binding on UHC.
• Expedited option: Available within 72 hours if urgent.

### Documentation to Gather

1. Diagnosis confirmation — psychiatric evaluation notes documenting diagnosis, current episode characteristics, and severity using a validated chart-documented scale. 2. Prior-treatment history with dates and outcomes — a comprehensive, dated list of every antidepressant and other psychiatric treatment tried, with the clinical rationale for stopping each. This is the most commonly cited gap in initial PA submissions. 3. Severity and functional impairment documentation — chart entries demonstrating how your condition impairs daily functioning, supporting the urgency and necessity of TMS. 4. Prescriber medical-necessity letter — a letter from your psychiatrist that specifically addresses each requirement in UHC's TMS prior-authorization criteria, referencing the applicable UHC policy by name.

### Criteria-Mapping Structure

Before submitting (or re-submitting) the prior-authorization request, obtain UHC's current TMS prior-authorization criteria and the NeuroStar FDA clearance documentation. Build a structured response that addresses each criterion verbatim and cites the specific chart evidence satisfying it. If the initial PA was denied for missing documentation rather than a clinical determination, a resubmission with the complete criteria-mapped documentation package often resolves the issue without proceeding to a formal appeal. For clinical denials, use the same criteria-mapping structure as the basis of your appeal letter.